Get the Daily Brief
Latest Biotech News
Develop Health Raises $14.3M to Streamline Prior Authorization
Develop Health secured $14.3 million in Series A funding led by Wing Venture Capital to enhance its platform streamlining prior authorization processes. This investment supports the company's...
Machine Learning Enhances Prostate Cancer Spread Prediction
A two-center study employing deep learning and multiparametric MRI habitat analysis has developed a method to predict perineural invasion in prostate cancer. This approach promises to refine...
Drug Repurposing Accelerates Oncology Breakthroughs
Recent research published in Medical Oncology highlights drug repurposing as an innovative strategy to overcome traditional barriers in cancer therapy development. This approach leverages existing...
AI-Driven Innovations Enhance Clinical and Diagnostics Platforms
Artificial intelligence continues to reshape healthcare with novel applications in patient care and diagnostics. Boston's Cascala Health secured $8.6 million to expand its AI platform that...
Neuroscience and Neurodegenerative Disease Insights Emerge
Groundbreaking studies advance the understanding of neurodegenerative disorders and brain function. A novel brain-shuttled antibody targets alpha-synuclein aggregates implicated in Parkinson's...
Cancer Therapeutics: Novel Agents and Biomarkers Propel Progress
Significant strides are being made in cancer biology and treatment modalities. Research reveals WTAP's role in hepatocellular carcinoma DNA repair via m6A-FOXM1 modulation. Collagen type VI alpha...
Advancements in Gene Therapy and Funding Landscape
The gene therapy sector continues to garner substantial investment and scientific breakthroughs. Kriya Therapeutics secured $313 million to advance a pipeline of gene therapies targeting...
Innovative Imaging and Diagnostic Technologies Transform Care
Novel advancements in medical imaging and diagnostics offer heightened precision and early detection capabilities. Autonomous robotic systems now perform expert-level carotid ultrasounds using...
Metabolic and Cardiovascular Disease Mechanisms Explored
Emerging studies elucidate complex interplays between metabolic and cardiovascular disorders. Research identifies a link between Type 2 diabetes and heart failure, providing clinical insights into...
Energy Storage Innovations Propel Battery Technology Forward
Research in advanced materials significantly enhances lithium-ion and other battery technologies. Novel cathode compositions such as MOF-enhanced Sn-doped V2O5 and lithium-rich graphene/zinc...
Regulatory and Policy Moves Affect Biotech Landscape
Critical regulatory changes shape the future of biomedical research and drug safety reporting. The FDA initiated daily public dissemination of adverse event reports, enhancing pharmacovigilance...
Environmental and Agricultural Science Advances
Novel scientific insights emerge across environmental and agricultural domains. Research on phytobiotic additives indicates enhanced broiler health post-pathogen challenge. DNA barcoding reveals...
AI startup Cascala raises $8.6M to cut hospital readmissions
Boston-based Cascala Health secured $8.6 million in seed funding to expand its AI platform targeting improvement of patient care transitions. The technology aims to reduce hospital readmissions...
Novo Nordisk's obesity drug Wegovy approved - patient targeting next hurdle
Following the historic approval of Novo Nordisk's obesity drug Wegovy, stakeholders emphasize the need to identify appropriate patient populations and implement strategies for early disease...
Gene therapy company Kriya raises $313 million for chronic diseases pipeline
Kriya Therapeutics completed a $313 million financing round to advance its portfolio of gene therapies targeting ophthalmic, metabolic, and neurologic chronic diseases. The investment follows...
Ionis Pharmaceuticals launches first-in-class drug for hereditary angioedema
Ionis Pharma’s Dawnzera received FDA approval as a preventive therapy for hereditary angioedema attacks, entering a competitive market dominated by Takeda’s existing medication. Clinical data...
LB Pharmaceuticals prepares IPO with antipsychotic nearing Phase III
LB Pharma is reportedly working with Leerink Partners on an initial public offering as its antipsychotic drug candidate approaches Phase III trials. This financing move aims to support late-stage...
AI detects prostate cancer cases missed by pathologists
Researchers at Uppsala University developed an AI tool that identifies subtle tissue changes indicative of prostate cancer, which were previously undetectable by pathologists. This technology...
Deep learning and MRI combine to predict prostate cancer spread
A novel approach using deep learning enhanced multiparametric MRI habitat analysis was shown in a two-center study to predict perineural invasion in prostate cancer. This advancement may provide...
Moffitt Cancer Center finds lymphoma accelerates aging of immune cells
A study from Moffitt Cancer Center reveals that lymphoma induces premature aging changes in immune cells and tissues, potentially impacting patient prognosis and treatment responses. Published in...